Kamar, Nassim <br/><br/>
Impact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney-transplant patients.  [electronic resource] 

 -  Transplant international : official journal of the European Society for Organ Transplantation  Mar 2010 
 - 277-84 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-2277 
<br/><br/><label>Standard No.: </label>10.1111/j.1432-2277.2009.00982.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia--blood<br/>Creatinine--blood<br/>Erythropoietin--administration & dosage<br/>Female<br/>Graft Survival--drug effects<br/>Hematinics--administration & dosage<br/>Hemoglobins--metabolism<br/>Humans<br/>Kidney--drug effects<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors